These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
767 related items for PubMed ID: 15570636
1. Therapeutic strategies in rheumatoid arthritis over a 40-year period. Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE. J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636 [Abstract] [Full Text] [Related]
2. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE. J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365 [Abstract] [Full Text] [Related]
3. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC. Scand J Rheumatol; 2009 Feb; 38(4):240-5. PubMed ID: 19229766 [Abstract] [Full Text] [Related]
4. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, Matteson EL. Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103 [Abstract] [Full Text] [Related]
5. The widening mortality gap between rheumatoid arthritis patients and the general population. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM, Therneau TM, Roger VL, Gabriel SE. Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923 [Abstract] [Full Text] [Related]
6. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy. Capell H, McCarey D, Madhok R, Hampson R. J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318 [Abstract] [Full Text] [Related]
7. Population-based mortality outcome of rheumatoid arthritis in females. Iacovino JR. J Insur Med; 2002 Oct; 34(2):86-8. PubMed ID: 15305782 [Abstract] [Full Text] [Related]
8. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC, Macarrón P, Pato E, Fernández-Gutiérrez B, Bañares A, Jover JA. J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824 [Abstract] [Full Text] [Related]
9. Cardiovascular death in rheumatoid arthritis: a population-based study. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097 [Abstract] [Full Text] [Related]
10. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study. Galindo-Rodriguez G, Aviña-Zubieta JA, Russell AS, Suarez-Almazor ME. J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887 [Abstract] [Full Text] [Related]
11. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE. Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992 [Abstract] [Full Text] [Related]
12. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital. de Thurah A, Nørgaard M, Johansen M, Stengaard-Pedersen K. Scand J Rheumatol; 2010 Feb; 39(1):19-25. PubMed ID: 20132066 [Abstract] [Full Text] [Related]
13. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA, RADIUS Investigators. Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444 [Abstract] [Full Text] [Related]
14. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378 [Abstract] [Full Text] [Related]
15. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? Gabriel SE, Crowson CS, O'Fallon WM. J Rheumatol; 1999 Dec; 26(12):2529-33. PubMed ID: 10606358 [Abstract] [Full Text] [Related]
16. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group. Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945 [Abstract] [Full Text] [Related]
17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. Nikolaisen C, Rekvig OP, Nossent HC. Scand J Rheumatol; 2005 May; 34(4):269-76. PubMed ID: 16195159 [Abstract] [Full Text] [Related]
18. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010 [Abstract] [Full Text] [Related]
19. Patterns of drug use in rheumatoid arthritis. Bérard A, Solomon DH, Avorn J. J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846 [Abstract] [Full Text] [Related]
20. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X, EMECAR Study Group. J Rheumatol; 2003 Apr; 30(4):697-704. PubMed ID: 12672186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]